TrialThe lancet. Psychiatry2020

Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial.

Tom P Freeman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.